Stock Taper
SCREENER COMPARE ANY 2 STOCKS
CLYM
CLIMB BIO, INC.
NASDAQ
$14.57
▼ DOWN 3.25% (-0.49)

KEY STATISTICS

Market Cap$834.32 M
52w High$18.33
52w Low$1.54
Dividend Yield—
Frequency—
P/E-17.55
Volume840.02K
Shares Out.57.26M

COMPANY

LEADERSHIP

Aoife Brennan BCh MMSc
CHIEF EXECUTIVE
Aoife Brennan BCh MMSc

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 10, 2021
METHOD OF GOING PUBLIC
N/A
FULL TIME EMPLOYEES
28

PRICE TARGET

Target High$35.00
Target Low$17.00
Target Median$22.50
Target Consensus$23.00

UPCOMING EARNINGS

DateNov 5, 2026
DayThursday
Rev. Est.—
NOV
5
THU

PRICE

$14.57 ▼ DOWN 3.25% (−$0.49)
$14.60$14.80$15.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM14.57

About Climb Bio, Inc.

https://climbbio.com ↗

Climb Bio, Inc., a Wilmington-based biotech founded in 2018, develops therapies like anti-CD19 antibody budoprutug for autoimmune diseases such as lupus, lupus nephritis, immune thrombocytopenia, and membranous nephropathy.

INDUSTRY

Biotechnology

A SERVICE CLIMB BIO, INC. IS KNOWN FOR

Development of monoclonal antibody therapeutics

Climb Bio, Inc. is a clinical-stage biotech developing therapeutics for immune and B-cell diseases, including anti-CD19 and anti-APRIL monoclonal antibodies for conditions like IgA nephropathy.

COMPETITORS

COMPETITOR
ABBV COMPARE
AGEN COMPARE
AMGN COMPARE
REGN COMPARE
VRDN COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
62
LISTED HERE
17
RANKED BY POSITION SIZE
VTI
0.00% · 1.4M
XSU.TO
0.02% · 902.6K
DWAS
1.31% · 375.3K
DFAS
0.01% · 76.9K
R2US.L
0.02% · 71.3K
SBIO
0.43% · 70.9K
VAMO
1.03% · 61.3K
AVSC
0.03% · 59.5K
AFSM
0.46% · 40.0K
GSSC
0.05% · 38.4K
XRS2.F
0.02% · 32.2K
BBC
0.79% · 27.4K
RSSL
0.02% · 16.7K
FMED
0.41% · 14.4K
TNXT
0.13% · 1.6K
URTY
0.01% · 1.4K
RESM
0.02% · 96

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity4
Price To Earnings1
Price To Book2
Overall Score2

INSIDER TRADES

★
DIRECTOR
Celebi Breanna Maurine
Purchase · 70.3K shares
2026-06-29
★
DIRECTOR, 10 PERCENT OWNER:
RA CAPITAL MANAGEMENT, L.P.
Purchase · 70.3K shares
2026-06-29
★
Celebi Breanna Maurine
— · —
2026-06-29
★
DIRECTOR, OFFICER: PRESIDENT AND CEO
Brennan Aoife
Purchase · 68.8K shares
2026-06-27

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
OUTPERFORM 3
6 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY Wedbush OUTPERFORM Truist Securities BUY BTIG BUY Oppenheimer OUTPERFORM Baird OUTPERFORM

SECTORS PEERS

PEERPRICE
AGEN$7.66COMPARE
TTRX$9.84COMPARE
ABOS$2.92COMPARE
ENTX$3.03COMPARE
ANIX$3.48COMPARE
INO$1.29COMPARE
SPRO$1.20COMPARE
MCRB$5.11COMPARE